Willman CL - Search Results

1

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.

Stirewalt DL, Kopecky KJ, Meshinchi S, Engel JH, Pogosova-Agadjanyan EL, Linsley J, Slovak ML, Willman CL, Radich JP. Stirewalt DL, et al. Among authors: willman cl. Blood. 2006 May 1;107(9):3724-6. doi: 10.1182/blood-2005-08-3453. Epub 2005 Dec 20. Blood. 2006. PMID: 16368883 Free PMC article. Clinical Trial.

2

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.

Radich JP, Kopecky KJ, Willman CL, Weick J, Head D, Appelbaum F, Collins SJ. Radich JP, et al. Among authors: willman cl. Blood. 1990 Aug 15;76(4):801-7. Blood. 1990. PMID: 2200539 Free article.

3

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

Mehrotra B, George TI, Kavanau K, Avet-Loiseau H, Moore D 2nd, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG. Mehrotra B, et al. Among authors: willman cl. Blood. 1995 Aug 1;86(3):1139-47. Blood. 1995. PMID: 7542497 Free article.

4

Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.

Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Leith CP, et al. Among authors: willman cl. Blood. 1995 Sep 15;86(6):2329-42. Blood. 1995. PMID: 7545025 Free article.

5

Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.

Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F, et al. Shurtleff SA, et al. Among authors: willman cl. Blood. 1995 Jun 15;85(12):3695-703. Blood. 1995. PMID: 7780153 Free article.

6

Trisomy 11: an association with stem/progenitor cell immunophenotype.

Slovak ML, Traweek ST, Willman CL, Head DR, Kopecky KJ, Magenis RE, Appelbaum FR, Forman SJ. Slovak ML, et al. Among authors: willman cl. Br J Haematol. 1995 Jun;90(2):266-73. doi: 10.1111/j.1365-2141.1995.tb05146.x. Br J Haematol. 1995. PMID: 7794746

7

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

Head DR, Kopecky KJ, Willman C, Appelbaum FR. Head DR, et al. Leukemia. 1994;8 Suppl 2:S38-41. Leukemia. 1994. PMID: 7815835 Clinical Trial.

8

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.

Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, et al. Kuss BJ, et al. Among authors: willman cl. Lancet. 1994 Jun 18;343(8912):1531-4. doi: 10.1016/s0140-6736(94)92938-6. Lancet. 1994. PMID: 7911871

9

Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.

Sievers EL, Smith FO, Woods WG, Lee JW, Bleyer WA, Willman CL, Bernstein ID. Sievers EL, et al. Among authors: willman cl. Leukemia. 1995 Dec;9(12):2042-8. Leukemia. 1995. PMID: 8609715 Clinical Trial.

10

The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.

Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Callen DF. Kuss BJ, et al. Among authors: willman cl. Leuk Lymphoma. 1996 Feb;20(5-6):357-64. doi: 10.3109/10428199609052416. Leuk Lymphoma. 1996. PMID: 8833390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters